Highlights

  • Marquee Resources shares rose 12.50% to AUD 0.009 on 9 April 2026 following a strategic update
  • Company secures R&D patent licence agreement with UT-Battelle, linked to Oak Ridge National Laboratory
  • Access to advanced rare earth separation technologies, including NEAREST and lanthanide methods
  • Agreement supports downstream processing potential for Redlings REE Project
  • Includes option to negotiate a commercial licence within 24 months across Australia and the United States

Marquee Resources Ltd (ASX:MQR) shares climbed 12.50% to AUD 0.009 during the morning session on 9 April 2026, following the release of a significant strategic update tied to rare earth processing technology. Despite the stock remaining down approximately 10% over the past year, the latest development appears to have renewed investor attention, particularly around the Company’s positioning in the critical minerals value chain.

Today’s share price reaction comes after Marquee announced it has entered into a Research and Development Patent License and Option Agreement with UT-Battelle LLC, the entity responsible for managing and operating Oak Ridge National Laboratory under a contract with the United States Department of Energy (DOE).

Strategic Technology Access Signals Shift Toward Higher-Value Processing

The agreement provides Marquee with access to a portfolio of patented technologies focused on the extraction and separation of rare earth elements (REE) and rare earth oxides (REO). This includes advanced methods such as the separation of adjacent lanthanide elements and the Neutral Ligand-Based Rare Earth Element Separation Technology (NEAREST).

Importantly, the licence is structured as a research and development agreement, allowing the Company to evaluate these technologies while also securing an option to negotiate a future commercial licence. The arrangement spans a 24-month term and applies across both Australia and the United States.

This development places Marquee within a formal intellectual property framework connected to a major U.S. national laboratory, which operates under the DOE. The linkage is viewed by the Company as a meaningful step in assessing advanced processing pathways that could potentially enhance the economic viability of its projects.

Redlings Project Remains Central to Growth Strategy

The licensed technologies will be applied to Marquee’s Redlings Rare Earth Project located in Western Australia. The project already holds a defined Mineral Resource Estimate of 11 million tonnes at 1,130 parts per million total rare earth oxides (TREO), containing 12,430 tonnes of REO. Within this, magnetic rare earth oxides account for 2,316 tonnes.

In addition to the existing resource, the Company has outlined a broader exploration target ranging between 204 million and 306 million tonnes, with grades between 950 and 1,130 ppm TREO. This highlights the potential scale surrounding the current resource base.

The agreement enables Marquee to explore whether advanced separation technologies can be integrated into the development pathway of Redlings, particularly as the industry increasingly focuses on downstream processing capabilities rather than just resource extraction.

Rare Earth Separation: A Critical Value Driver

Marquee emphasised that rare earth separation represents a key bottleneck in the critical minerals supply chain. While resource discovery remains important, the ability to efficiently separate and refine rare earth elements is often where the majority of value is realised.

The Company noted that traditional separation processes can be technically complex and cost-intensive. As such, access to alternative methodologies—especially those linked to established research institutions—could play a role in improving both efficiency and cost outcomes.

Rare earth elements are essential inputs across a wide range of industries, including electric vehicles, wind energy, defence systems, aerospace, robotics, and advanced electronics. This broad application base continues to drive strategic interest in securing reliable and scalable supply chains

Structured Pathway from Research to Commercialisation

A key feature of the agreement is its structured pathway toward potential commercialisation. While the current licence is limited to research and development, Marquee retains the option to negotiate a commercial licence for the application of the technology to its projects.

The agreement outlines several milestones, including:
• Proof-of-concept testing using up to three different ore types by September 2026
• Development of a prototype separation product by June 2027
• Potential application for a commercial licence by February 2028

Additionally, the Company is required to reimburse UT-Battelle for patent-related costs during the licence term, although there is no minimum funding obligation attached to the agreement.

Positioning for Downstream Opportunities

Marquee views the agreement as a strategic step toward expanding its role beyond upstream exploration into downstream processing. By evaluating how advanced separation technologies could integrate with its existing resource base, the Company aims to better understand potential pathways to higher-value product streams.

The combination of resource ownership and access to processing intellectual property may broaden Marquee’s strategic positioning within the rare earth sector. This approach aligns with broader industry trends, where companies are increasingly seeking to capture value across multiple stages of the supply chain.

What This Means for Investors?

The 12.50% share price increase suggests that investors are responding positively to Marquee’s move into technology-linked processing capabilities. While the Company’s shares remain down over the past year, today’s update highlights a potential shift in strategic direction.

The agreement does not immediately translate into revenue but provides a framework for evaluating advanced processing options that could influence future project economics. Investors are likely to monitor progress against the outlined milestones, particularly proof-of-concept results and any movement toward commercial licensing.